
The oncology market in the United States is expanding rapidly, driven by a growing need for oncology diagnostics and treatment amid a rising prevalence of various types of cancer due to increasing lifestyle diseases and an aging population. The oncology market also benefited from new opportunities created by the COVID-19 pandemic, including a shift to telemedicine and telehealth, and AI-based analytics.
According to a report by Precedence Research, the global oncology market is projected to reach $581.25 billion by 2030, growing at an 8.2% CAGR. The growing awareness regarding the availability of various drugs and diagnostics related to oncology is expected to boost the market's growth.